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Trends in Nonmelanoma Skin Cancer Mortality Rates
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Kevan G. Lewis1 and Martin A. Weinstock2
The purpose of this population-based study was to assess trends in mortality rates for nonmelanoma skin
cancer (NMSC) in the United States. Particular emphasis was placed on the subgroup of malignancies arising on
genital skin. Nearly 75,000 deaths in the United States were attributed to NMSC from 1969 to 2000. The age-
adjusted US mortality rate for NMSC arising on nongenital skin from 1969 to 2000 was 0.69/105/year; the rate
among men was twice that among women. Mortality rates among white men exceeded that of black men by a
factor of two; the same was observed among women, but by a smaller multiple. Corresponding mortality rates
for malignancies arising from genital skin (penis, scrotum, vulva) were higher in women (0.54) than in men
(0.30). In contrast to nongenital NMSC, mortality rates among black men were twice that of white men; however,
rates for white and black women were similar. These results suggest that greater emphasis could be placed on
reducing mortality from genital NMSC while continuing to stress reduction of excess sun exposure.
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INTRODUCTION
Nonmelanoma skin cancer (NMSC) is the most common
malignancy in the United States and its incidence is rapidly
increasing (Boring et al. 1991; Karagas et al. 1999). Despite
the magnitude of the public health burden, investigation of
mortality from NMSC has been limited. Previous studies
suggest that NMSC mortality rates in Germany (Stang and
Jockel, 2004) and the United States declined through the
latter part of the twentieth century (Weinstock et al. 1991;
Weinstock 1993). However, the precision of these data can
be questioned.
Accuracy with respect to cause of death certification has
been examined in Rhode Island from 1979 through 2000.
Results of these studies revealed that a significant proportion
of deaths attributed to NMSC under International Classifica-
tion of Disease (ICD) coding rubrics were misclassified and
not due to NMSC (Weinstock et al. 1991; Lewis and
Weinstock, 2004). Further investigation of this issue sug-
gested that the problem of misclassification was not
uncommon among public health departments across the
United States (Weinstock et al. 1992). Correction for
probable sources of misclassification is believed to proffer a
more accurate estimate of trends in NMSC mortality rates in
the United States.
The purpose of this study was to investigate trends in
NMSC mortality rates in the United States from 1969 to 2000.
Special emphasis was placed on mortality from genital skin
cancers. To our knowledge, a population-based estimate of
mortality rates for this subgroup of NMSC has not been
reported previously.
RESULTS
There were 73,572 deaths attributed to NMSC in the United
States from 1969 to 2000. Of these, 44,630 deaths resulted
from primary tumors arising on nongenital skin (26,759 in
men and 17,871 in women). An additional, 28,942 deaths
were attributed to NMSC on genital skin (7,791 in men and
21,115 in women). Thus, the number of deaths attributed to
vulvar skin cancer exceeded that of penile–scrotal skin cancer
by nearly a factor of three. The age-adjusted US mortality rate
from 1969 to 2000 was 0.69 (/105/year) for nongenital
NMSC, 0.30 for genital NMSC in men, and 0.54 for genital
NMSC in women. In 1999 and 2000 in the United States, an
average of 865 men and 571 women died per year of
nongenital NMSC, another 220 men and 757 women died of
genital NMSC.
Nongenital NMSC
Of the 44,630 deaths attributed to nongenital NMSC, 41,585
(93%) occurred in whites and 2,752 (6%) occurred in blacks.
Mortality rates for nongenital NMSC were strongly age-
related with the highest crude rate occurring in the oldest age
group (Table 1). Exclusive of NMSC arising on genital skin,
the age-adjusted mortality rate for nongenital NMSC was
0.69 (1.02 in men and 0.46 in women). The rate among white
men (1.09) was higher than that among black men (0.54) by a
factor of two, whereas rates for white women (0.48) here
were modestly higher than that of black women (0.38).
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Mortality rates generally declined over time, although the
proportional decline among blacks (43% in men and 51% in
women) was greater than that among whites (27% in men
and 30% in women) (Table 2).
Mortality rates in white men declined consistently from
1969 to 2000 with the notable exception of the interval from
1981 to 1988 during which a sharp increase in mortality rates
was observed (Figure 1). A similar rise in the mortality rates
for black men was also seen during the same time interval.
During these years the proportion of deaths occurring in
males under 60 years of age increased more than twofold to
nearly 50% of all deaths attributed to nongenital NMSC.
There was no significant change in the number of deaths
occurring in men over 60 years. The number of deaths and
the mortality rate returned quickly to the pre-1980 trend-line
following this time period. The aberrancy was limited to
nongenital skin cancers; mortality rates for NMSC on genital
skin did not fluctuate during this period. This period
corresponds to the years in which deaths due to AIDS-related
Kaposi’s sarcoma were coded under NMSC rubrics. Subse-
quent revisions in the ICD reassigned these causes of deaths
to alternate rubrics. By contrast, nongenital NMSC mortality
rates for white and black women declined steadily over time.
Although uncorrected NMSC mortality rate calculations
(i.e., based on records coded under the 173.0–173.9 rubrics)
are thought to be less accurate because of misclassification of
the underlying cause-of-death, uncorrected age-adjusted US
NMSC mortality rates are presented to facilitate comparison
with results of international studies of NMSC mortality
(Table 3).
Table 1. Age-specific NMSC mortality rates in the United States, 1969–2000
Genital
Age group Nongenital rate (no.) Men Women
00–54 years 0.75 (6,922) 0.04 (1,174) 0.06 (1,725)
55–64 years 0.89 (6,047) 0.50 (1,575) 0.65 (2,320)
65–74 years 1.90 (9,766) 0.97 (2,150) 1.73 (5,006)
75–84 years 4.35 (12,069) 1.89 (1,961) 3.99 (6,919)
85+ years 11.91 (9,826) 4.09 (965) 8.73 (5,181)
NMSC, nonmelanoma skin cancer.
Rates are expressed as the number of deaths per 105 at-risk individuals per year.
Table 2. Age-adjusted NMSC mortality rates in the United States, 1969–2000
1969–1974 1975–1984 1985–1994 1995–2000
Genital
Men 0.42 (n=1,688) 0.32 (2,463) 0.25 (2,238) 0.22 (1,402)
Whites 0.37 (1,306) 0.29 (1,982) 0.23 (1,877) 0.21 (1,213)
Blacks 1.0 (369) 0.67 (455) 0.44 (328) 0.31 (164)
Women 0.67 (3,558) 0.54 (6,021) 0.50 (6,907) 0.48 (4,665)
Whites 0.65 (3,175) 0.54 (5,479) 0.50 (6,230) 0.50 (4,305)
Blacks 0.76 (363) 0.52 (515) 0.53 (625) 0.37 (316)
Nongenital
Men 1.14 (4,154) 1.08 (7,962) 1.02 (9,360) 0.79 (5,128)
Whites 1.20 (3,923) 1.14 (7,535) 1.10 (8,793) 0.87 (4,880)
Blacks 0.63 (231) 0.55 (427) 0.59 (567) 0.36 (248)
Women 0.58 (2,873) 0.49 (5,486) 0.42 (5,743) 0.37 (3,631)
Whites 0.58 (2,648) 0.50 (5,073) 0.44 (5,319) 0.40 (3,414)
Blacks 0.51 (225) 0.42 (413) 0.35 (424) 0.25 (217)
NMSC, nonmelanoma skin cancer.
Rates are age-adjusted to the 2000 US standard population and are expressed as the number of deaths per 105 at-risk individuals per year.
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Genital NMSC
Of the 7,791 deaths attributed to genital NMSC in men, 6,378
(82%) occurred in white men and 1,316 (17%) occurred in
black men. Of the 21,156 deaths attributed to genital NMSC
in women, 19,189 (91%) occurred in white women and
1,819 (9%) occurred in black women. Mortality rates for
genital NMSC were strongly age-related with the highest
crude rate occurring in the oldest age group for both men and
women (Table 1).
The age-adjusted mortality rate for primary tumors of
genital skin was 0.30 in men and 0.54 in women (Figure 2).
The rate among black men (0.59) was greater than that
among white men (0.27), whereas rates for black and white
women were the same (0.54). In recent years, the annual
mortality rates among men have converged although rates
among black men were notably higher during the 1970s and
were nearly three times those of white men during this time.
Mortality rates in both white and black women declined over
time. During the last two decades, mortality rates in white
women remained relatively steady, whereas rates in black
women continued to decline. During the last 6 years of the
study, mortality rates in white women exceeded that in black
women (Figure 2).
DISCUSSION
The age-adjusted US mortality rate for nongenital NMSC was
0.69 from 1969 to 2000. Rates were strongly age-related and
generally declined over time. Although mortality rates among
white men were notably higher than among black men, rates
among white and black women were less disparate. The
corresponding rates for genital NMSC were 0.30 in men and
0.54 in women. Rates were strongly age-related and
generally declined over time. Mortality rates for genital
NMSC among black men were substantially higher than
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Figure 1. Nongenital NMSC mortality rates in the United States,
1969–2000.
Table 3. Uncorrected age-adjusted ICD-9 173.x
mortality rates in the United States, 1969–2000
Year Male Female Total
1969 1.5 0.7 1.0
1970 1.3 0.7 0.9
1971 1.4 0.6 0.9
1972 1.4 0.6 0.9
1973 1.3 0.6 0.9
1974 1.3 0.6 0.9
1975 1.3 0.6 0.9
1976 1.3 0.6 0.9
1977 1.4 0.6 0.9
1978 1.3 0.6 0.9
1979 1.2 0.5 0.8
1980 1.3 0.4 0.8
1981 1.3 0.4 0.8
1982 1.4 0.5 0.8
1983 1.6 0.5 0.9
1984 1.6 0.5 0.9
1985 1.7 0.4 1.0
1986 1.8 0.5 1.0
1987 1.6 0.5 0.9
1988 1.6 0.5 0.9
1989 1.7 0.5 1.0
1990 1.7 0.4 0.9
1991 1.6 0.5 0.9
1992 1.6 0.5 0.9
1993 1.5 0.4 0.9
1994 1.5 0.4 0.9
1995 1.4 0.4 0.8
1996 1.3 0.4 0.8
1997 1.3 0.4 0.8
1998 1.3 0.4 0.8
1999 1.5 0.4 0.9
2000 1.4 0.4 0.8
ICD, International Classification of Disease.
Rates are age-adjusted to the US 2000 standard population and expressed
as the number of deaths per 105 at-risk individuals.Data are derived from
the SEER cancer query resource http://seer.cancer.gov/canques/mortali-
ty.html (accessed 9 March, 2007).
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among white through the 1970s although rates between these
two groups appear to have converged in recent years. Rates
among white and black women have been comparable over
time; mortality rates among white women slightly exceeded
that among black women during the 1990s.
The data presented herein are comprehensive and provide
population-based estimates for NMSC in the United States.
However, there are several limitations to this study that
should be acknowledged. NMSC mortality data for the US
population is pooled from individual state public health
departments that in turn rely on cause of death certification
for deaths among individuals who reside in their respective
states. Death certificates were certified by licensed physicians
who may or may not have cared for the deceased during the
course of their diseases. Post-mortem examinations are
performed rarely in the United States. Therefore, in cases of
advanced local or metastatic NMSC, the histology of the
primary tumor may not be evident. In particular, frank
ulceration of the face from a squamous cell carcinoma that
originated in the oral mucosal may appear clinically to have
originated on the skin in the advanced stages of disease.
Evidence for this potential source of error is available from a
detailed review of medical records in Rhode Island in which
many deaths attributed (on death certificates) to NMSC were
actually misclassified (Lewis and Weinstock, 2004). The
173.4 rubric largely captured these misclassified cases, so
deaths coded under this rubric were excluded from this study.
In addition, US mortality data do not include deaths due to
NMSC that were incorrectly classified under a different cause
of death. This source of misclassification would result in an
underestimation of true mortality rates. Periodic revisions of
the ICD may also introduce artifactual changes in mortality
rates owing to the creation, deletion, inclusion, or exclusion
of specific coding rubrics within general categories.
We are unaware of previous population-based estimates of
mortality rates for genital skin cancer. The estimated US
mortality rates for vulvar and penile skin cancer suggest that
mortality due to genital NMSC represents about half of all
deaths due to NMSC in this country. In addition, although
men are three times as likely to die from nongenital NMSC as
NMSC of the penis and scrotum, mortality rates among
women are actually slightly higher for vulvar skin cancer than
for nongenital NMSC. The magnitude of the public health
burden is great; nevertheless, efforts on the part of the
dermatology community to prevent human papilloma virus
infection in the United States have been slight compared to
similar effort to reduce excess exposure to UV light. These
data suggest that greater emphasis could be placed on the risk
of mortality from genital skin cancer, both in efforts with
patients and with physicians in related specialties such as
family medicine and obstetrics–gynecology.
MATERIALS AND METHODS
The data presented herein are derived from the records of the vital
statistics of the US National Center for Health Statistics and include
all reported deaths attributed to NMSC from 1969 to 2000. The ICD-
9 coding rubrics 173 (NMSC), 184 (vulvar skin cancer, excluding
184.0), 187 (penile and scrotal skin cancer), 154.3 (perianal skin),
176.0 (non-AIDS-related Kaposi’s sarcoma of the skin), and 140
(including 140.0, 140.1, and 140.9; NMSC of the lip) were included.
Cutaneous lymphomas (ICD-9 202.1, 202.2 and ICD-10 C84.0,
C84.1) were excluded. Subsequently, deaths coded under ICD-9
rubric 173.4 were excluded to correct for a probable source of
misclassification.(Lewis and Weinstock, 2004) Unless otherwise
specified, calculated mortality rates exclude rubric 173.4 and are
age-adjusted to the US 2000 standard population. Rates are
expressed as the number of deaths per 105 at risk individuals per
year. Denominators of calculated mortality rates are derived from
point estimates of the US population obtained from the US Census
Bureau. Definitions of race and gender are those used by the 2000
US census.
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